Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 579

1.

The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.

Roh YH, Kim YH, Lee HW, Kim SJ, Roh MS, Jeong JS, Jung GJ.

Hepatogastroenterology. 2007 Sep;54(78):1641-4.

PMID:
18019683
[PubMed - indexed for MEDLINE]
2.

Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.

Zhou H, Schaefer N, Wolff M, Fischer HP.

Am J Surg Pathol. 2004 Jul;28(7):875-82.

PMID:
15223956
[PubMed - indexed for MEDLINE]
3.

Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.

de Paiva Haddad LB, Patzina RA, Penteado S, Montagnini AL, da Cunha JE, Machado MC, Jukemura J.

J Gastrointest Surg. 2010 Apr;14(4):719-28. doi: 10.1007/s11605-010-1156-4. Epub 2010 Jan 27.

PMID:
20107918
[PubMed - indexed for MEDLINE]
4.

Pathogenesis of carcinoma of the papilla of Vater.

Fischer HP, Zhou H.

J Hepatobiliary Pancreat Surg. 2004;11(5):301-9. Review.

PMID:
15549428
[PubMed - indexed for MEDLINE]
5.

Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.

Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM.

Am J Surg Pathol. 2005 Mar;29(3):359-67.

PMID:
15725805
[PubMed - indexed for MEDLINE]
6.

Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.

Park JS, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, Kim BR.

J Surg Oncol. 2007 Mar 15;95(4):286-90.

PMID:
17326125
[PubMed - indexed for MEDLINE]
7.

Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis.

Kitamura H, Yonezawa S, Tanaka S, Kim YS, Sato E.

Jpn J Cancer Res. 1996 Jun;87(6):631-40.

PMID:
8766528
[PubMed - indexed for MEDLINE]
8.

Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.

Morini S, Perrone G, Borzomati D, Vincenzi B, Rabitti C, Righi D, Castri F, Manazza AD, Santini D, Tonini G, Coppola R, Onetti Muda A.

Pancreas. 2013 Jan;42(1):60-6. doi: 10.1097/MPA.0b013e318258fda8.

PMID:
22889982
[PubMed - indexed for MEDLINE]
9.

High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases.

Nassar H, Albores-Saavedra J, Klimstra DS.

Am J Surg Pathol. 2005 May;29(5):588-94.

PMID:
15832081
[PubMed - indexed for MEDLINE]
10.

Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.

Hansel DE, Maitra A, Lin JW, Goggins M, Argani P, Yeo CJ, Piantadosi S, Leach SD, Biankin AV.

J Clin Oncol. 2005 Mar 20;23(9):1811-8.

PMID:
15774774
[PubMed - indexed for MEDLINE]
Free Article
11.

Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.

Lee JH, Lee KG, Ryou H, Jun YJ, Paik SS, Park HK, Lee KS.

Hepatogastroenterology. 2010 May-Jun;57(99-100):646-52.

PMID:
20698243
[PubMed - indexed for MEDLINE]
12.

Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.

Kawabata Y, Tanaka T, Nishisaka T, Inao T, Nishi T, Yano S.

Diagn Pathol. 2010 Nov 25;5:75. doi: 10.1186/1746-1596-5-75.

PMID:
21106111
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.

Sanada Y, Yoshida K, Konishi K, Oeda M, Ohara M, Tsutani Y.

Oncol Rep. 2006 May;15(5):1157-61.

PMID:
16596179
[PubMed - indexed for MEDLINE]
14.

Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.

Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Kijima H, Saito T.

Cancer. 1999 Aug 15;86(4):596-607.

PMID:
10440687
[PubMed - indexed for MEDLINE]
15.

Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).

Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A.

Hepatogastroenterology. 1999 Mar-Apr;46(26):1187-91.

PMID:
10370689
[PubMed - indexed for MEDLINE]
16.

Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater.

Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, Esaki Y.

Jpn J Cancer Res. 1994 Feb;85(2):161-6.

PMID:
7511574
[PubMed - indexed for MEDLINE]
17.

[Cytokeratins 7 and 20 immunohistochemistry in ampullary carcinomas].

Le Pessot F, Ranty ML, Hellot MF, Lemoine F, Ténière P, Testart J, Métayer J.

Ann Pathol. 2004 Sep;24(4):312-8. French.

PMID:
15567946
[PubMed - indexed for MEDLINE]
18.

Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.

Zhao XQ, Dong JH, Zhang WZ, Liu Z.

Diagn Pathol. 2011 Oct 13;6:98. doi: 10.1186/1746-1596-6-98.

PMID:
21992455
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.

Qiao QL, Zhao YG, Ye ML, Yang YM, Zhao JX, Huang YT, Wan YL.

World J Surg. 2007 Jan;31(1):137-43; discussion 144-6.

PMID:
17171495
[PubMed - indexed for MEDLINE]
20.

Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.

Takashima M, Ueki T, Nagai E, Yao T, Yamaguchi K, Tanaka M, Tsuneyoshi M.

Mod Pathol. 2000 Dec;13(12):1300-7.

PMID:
11144926
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk